1. Home
  2. FHN vs RGEN Comparison

FHN vs RGEN Comparison

Compare FHN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Horizon Corporation

FHN

First Horizon Corporation

HOLD

Current Price

$23.63

Market Cap

11.0B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$156.66

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHN
RGEN
Founded
1864
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FHN
RGEN
Price
$23.63
$156.66
Analyst Decision
Buy
Buy
Analyst Count
20
10
Target Price
$24.20
$170.90
AVG Volume (30 Days)
5.7M
724.0K
Earning Date
01-15-2026
10-28-2025
Dividend Yield
2.54%
N/A
EPS Growth
20.88
N/A
EPS
1.65
0.03
Revenue
$3,184,000,000.00
$707,890,000.00
Revenue This Year
$12.70
$17.84
Revenue Next Year
$2.54
$12.57
P/E Ratio
$14.25
$5,097.58
Revenue Growth
3.68
11.74
52 Week Low
$15.19
$102.97
52 Week High
$24.11
$182.52

Technical Indicators

Market Signals
Indicator
FHN
RGEN
Relative Strength Index (RSI) 66.10 47.50
Support Level $22.63 $160.11
Resistance Level $24.11 $165.02
Average True Range (ATR) 0.46 4.97
MACD 0.17 -1.27
Stochastic Oscillator 78.94 7.12

Price Performance

Historical Comparison
FHN
RGEN

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: